BioScrip (BIOS +1.7%) moves up after announcing earlier today that it was buying infusion...
Thursday, December 13, 2012, 12:46 PM ETBioScrip (BIOS +1.7%) moves up after announcing earlier today that it was buying infusion pharmacy services provider HomeChoice Partners for $70M in cash from DaVita HealthCare Partners (DVA -0.3%). The deal is part of a larger effort by BIOS to expand its national footprint. In February, it sold its specialty and mail-service pharmacy operations to Walgreen (WAG)for $225M, saying it wanted to turn its focus onto building its alternate-site infusion business.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles